ask="19.50"
ask_size="1000"
average_daily_volume="159671"
bid="14.24"
bid_size="2500"
book_value="6.55"
change="+1.00"
change_from_200_day_moving_average="0.37"
change_from_50_day_moving_average="-0.74"
change_from_52_week_high="-3.63"
change_From_52_week_low="3.85"
change_in_percent="+6.72%"
close="15.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.08"
high_52_weeks="19.50"
last_trade_date="1/31/2017"
last_trade_price="15.87"
last_trade_size="9172"
last_trade_time="4:00pm"
low="14.66"
low_52_weeks="12.02"
market_capitalization="348.85M"
moving_average_200_day="15.50"
moving_average_50_day="16.61"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.67"
open="14.75"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+2.40%"
percent_change_from_50_day_moving_average="-4.48%"
percent_change_from_52_week_high="-18.62%"
percent_change_from_52_week_low="+32.03%"
previous_close="14.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.27"
price_per_sales="308.66"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="18.93"
stock_exchange="NGM"
symbol="ADMS"
volume="138959"
weeks_range_52="12.02 - 19.50"
